510(k) K001552
K001552 is an FDA 510(k) premarket notification submitted by Phoenix Biotech Corp. for the device "TREPCHEK TREPONEMAL ANTIBODY EIA". The FDA issued a decision of Substantially Equivalent on October 19, 2000. The device falls under product code LIP (Enzyme Linked Immunoabsorption Assay, Treponema Pallidum), a Class II device regulated under 21 CFR 866.3830. Phoenix Biotech Corp. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 19, 2000
- Date Received
- May 18, 2000
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type